(R)-(-)-3-Aminopiperidine dihydrochloride CAS 334618-234 Puritas ≥99.0% ee ≥99.0% Factory

Description:

Nomen: (R)-(-)-3-Aminopiperidine dihydrochloride

CAS: 334618-23-4

Aspectus: Albus Firmus

Puritas: ≥99.0% (HPLC)Puritas optica: ee ≥99.0%

Chiral Compounds, Commercial Production

Inquiry: alvin@ruifuchem.com


Product Detail

Related Products

Product Tags

Descriptio:

Manufacturer Supple cum High puritate et stabulo Quality
(R)-(-)-3-Aminopiperidine dihydrochloride CAS 334618-23-4
(S)-(+)-3-Aminopiperidine dihydrochloride CAS 334618-07-4
Chiral Compounds, High Quality, Commercial Production

Chemical Properties:

Nomen chemicum (R)-(-)-3-Aminopiperidine dihydrochloride
Synonyma (R) -(-)-3-Piperidinamine Dihydrochloride
CAS Number 334618-23-4
CATTUS Number RF-PI250
Stock Status In Stock, Productio Ascendite ad Tons
Formulae hypotheticae C5H12N2·2HCl
M. Pondus 173.08
Liquescens punctum 190.0~ 195.0℃
Solubilitas Solutum in aqua
Shipping Condition Uit sub Ambient Temperature
Brand Ruifu Chemical

Specifications:

Item Specifications
Aspectus Solidus albus
IR Conformed
Puritas chemica ≥99.0% (HPLC)
Omnis immunditia ≤0.20%
Optical Puritas e ≥99.0%
Humor (KF) ≤0.50%
Damnum in Siccatio ≤0.50%
Residere in Ignition ≤0.10%
Test Standard Enterprise Standard
Consuetudinem Medium Linagliptin, Alogliptin, Trelagliptin

Sarcina & Repono:

sarcina: Utrem, aluminium foil, sacculum, 25kg/tympanum cardboard, vel secundum exigentiam emptoris

Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine, humore

commoda:

1

FAQ:

2

Applicatio:

Shanghai Ruifu Chemical Co., Ltd. est primarius fabrica et supplementum (R)-(-)-3-Aminopiperidine dihydrochloridis (CAS: 334618-23-4) cum qualitate magna, in synthesi organica late adhibita, synthesis intermediorum pharmaceutical. et activa medicamentis medicamentis (API) synthesis.Compositio chiralis (R)-(-)-3-Aminopiperidine dihydrochloride (CAS: 334618-23-4) adhiberi potest ut Linagliptin Intermedia, Alogliptin Intermedia, Trelagliptin Intermedia.

Epistulam tuam hic scribe et mitte nobis